Lung Cancer and Personalized Medicine: Current Knowledge and Therapies by Aamir AhmadLung Cancer and Personalized Medicine: Current Knowledge and Therapies by Aamir Ahmad

Lung Cancer and Personalized Medicine: Current Knowledge and Therapies

byAamir AhmadEditorShirish Gadgeel

Paperback | March 27, 2019

Pricing and Purchase Info


Earn 1,208 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer-statistics and epidemiology of lung cancer-along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer-immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.

Aamir Ahmad, PhD, is a Scientist at the Wayne State University School of Medicine, Department of Pathology, and the Karmanos Cancer Institute. He has been a member of leading cancer organizations such as the American Association for Cancer Reseasrch and the Union for International Cancer Control. In addition to serving as a reviewer fo...
Title:Lung Cancer and Personalized Medicine: Current Knowledge and TherapiesFormat:PaperbackDimensions:228 pagesPublished:March 27, 2019Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3319795929

ISBN - 13:9783319795928


Table of Contents

1 Lung Cancer Statistics.- 2 Epidemiology of Lung Cancer.- 3 Lung Cancer In Never Smokers.- 4 Immune Therapy.- 5 Anti-angiogenesis in personalized therapy of lung cancer.- 6 Target therapy in Lung Cancer.- 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update.- 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy.- 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer.- 10 Chemotherapy Resistance in Lung Cancer.- 11 Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.